不同的探头放置方式对超声引导下桡动脉穿刺的影响

注册号:

Registration number:

ChiCTR2000034790 

最近更新日期:

Date of Last Refreshed on:

2020-10-13 12:30:52 

注册时间:

Date of Registration:

2020-07-19 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同的探头放置方式对超声引导下桡动脉穿刺的影响

Public title:

Application of ultrasound probe perpendicular to the needle approach for radial artery puncture

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同的探头放置方式对超声引导下桡动脉穿刺的影响

Scientific title:

Application of ultrasound probe perpendicular to the needle approach for radial artery puncture

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张霜 

研究负责人:

梅伟 

Applicant:

Shuang Zhang 

Study leader:

Wei Mei 

申请注册联系人电话:

Applicant telephone:

+86 13882705707

研究负责人电话:

Study leader's
telephone:

+86 130 0616 2508

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

giggle5707@163.com

研究负责人电子邮件:

Study leader's E-mail:

wmei@hust.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省武汉市硚口区解放大道1095号

研究负责人通讯地址:

湖北省武汉市硚口区解放大道1095号

Applicant address:

1095 Jiefang Avenue, Qiaokou District, Wuhan, Hubei, China

Study leader's address:

1095 Jiefang Avenue, Qiaokou District, Wuhan, Hubei, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

华中科技大学同济医学院附属同济医院麻醉科

Applicant's institution:

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of science and technology

研究负责人所在单位:

华中科技大学同济医学院附属同济医院麻醉科

Affiliation of the Leader:

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of science and technology

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

【2020】伦审字(S141)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

华中科技大学同济医学院伦理委员会

Name of the ethic committee:

Ethics Committee of Tongji Medical College of Huazhong University of Science and Technology

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-05 00:00:00

伦理委员会联系人:

陈汇

Contact Name of the ethic committee:

Hui Chen

伦理委员会联系地址:

湖北省武汉市航空路13号

Contact Address of the ethic committee:

13 Hangkong Road, Wuhan, Hubei, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

华中科技大学同济医学院附属同济医院麻醉科

Primary sponsor:

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

研究实施负责(组长)单位地址:

湖北省武汉市硚口区解放大道1095号

Primary sponsor's address:

1095 Jiefang Avenue, Qiaokou District, Wuhan, Hubei, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北省

市(区县):

湖北

Country:

China

Province:

Hubei

City:

Hubei

单位(医院):

华中科技大学同济医学院附属同济医院麻醉科

具体地址:

湖北省武汉市硚口区解放大道1095号

Institution
hospital:

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of science and technology

Address:

1095 Jiefang Avenue, Qiaokou District, Wuhan, Hubei, China

经费或物资来源:

Source(s) of funding:

No

研究疾病:

桡动脉穿刺置管  

Target disease:

Radial arterial cannulation

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

比较传统的超声束——皮肤垂直和超声束——穿刺针垂直两种方式对桡动脉穿刺的影响。  

Objectives of Study:

This study is designed to observe the effect of modified ultrasound guidance technique compared to the traditional technique for radial artery cannulation in adult surgical patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1) 妊娠期、哺乳期妇女;
2) Allen 试验或改良Allen 试验阳性;
3) 尺动脉阻塞、出血性休克、糖尿病,以及曾多次动脉穿刺的患者;
4)正参加其它临床试验的患者;
5) 研究人员认为其他原因不适合临床试验者

Exclusion criteria:

1. Pregnant and lactating women;
2. Patients with positive Allen test or modified Allen test;
3. Patients with ulnar artery obstruction, hemorrhagic shock, diabetes mellitus, and patients who had been punctured several times;
4. Patients who are participating in other clinical trials;
5. Patients who are considered unsuitable for clinical trials due to other reasons.

研究实施时间:

Study execute time:

From 2020-07-27 00:00:00 To 2021-07-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-07-27 00:00:00 To 2021-07-01 00:00:00

干预措施:

Interventions:

组别:

超声束——皮肤垂直/超声束——穿刺针垂直

样本量:

61

Group:

Ultrasound probe perpendicular to the needle group versus traditional ultrasound probe perpendicular to the skin (U-P-skin) group

Sample size:

干预措施:

不同探头放置方式

干预措施代码:

Intervention:

Different probe placement

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北 

市(区县):

武汉 

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

华中科技大学同济医学院附属同济医院麻醉科 

单位级别:

三级甲等 

Institution
hospital:

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

首次插管时间

指标类型:

主要指标

Outcome:

Cannulation time at first attempt

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

插管总时长

指标类型:

主要指标

Outcome:

Total puncture procedure duration

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

动脉直径

指标类型:

次要指标

Outcome:

arterial inner diameter

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

动脉深度

指标类型:

次要指标

Outcome:

radial arterial depth

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血栓

指标类型:

副作用指标

Outcome:

thrombosis

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血肿

指标类型:

副作用指标

Outcome:

hematoma

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

穿刺次数

指标类型:

主要指标

Outcome:

number of attempts

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

一名研究员采用SPSS软件生成随机数字表将入组病例随机分为两组,并将分组情况放在信封中。

Randomization Procedure (please state who generates the random number sequence and by what method):

Using a sealed envelope method, patients are randomly and equally assigned into two groups.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内公开,ResMan临床试验公共管理平台。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Data will be uploaded to ResMan Clinical Trial Management Public Platform within six months after trail complete.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病历记录表采集试验数据,研究数据录入 Epidata,在专用电脑内保存。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form will be employed for data collection,and Epidata for data management.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-07-19 21:15:48